[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Amgen Inc (AMGN)

Amgen Inc (AMGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

Is Merck & Co. Stock Outperforming the S&P 500?

Rahway, New Jersey-based Merck & Co., Inc. (MRK) is an international healthcare company that offers human health pharmaceuticals across various areas, including Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, and other brands. Valued at a market cap of $297 billion, the company also provides veterinary pharmaceuticals, vaccines and health management solutions and services.

Companies with a market cap of $200 billion or more are typically referred to as “mega-cap stocks.” Jabil fits right into that category, with its market cap exceeding this threshold, reflecting its substantial size and influence in the general drug manufacturers industry. 

Fundamentals

See More
  • Market Capitalization, $K 181,768,256
  • Shares Outstanding, K 539,708
  • Annual Sales, $ 36,751 M
  • Annual Income, $ 7,711 M
  • EBIT $ 10,568 M
  • EBITDA $ 16,935 M
  • 60-Month Beta 0.44
  • Price/Sales 4.94
  • Price/Cash Flow 9.95
  • Price/Book 19.76

Options Overview Details

View History
  • Implied Volatility 24.96% (+0.04%)
  • Historical Volatility 24.21%
  • IV Percentile 33%
  • IV Rank 28.92%
  • IV High 37.98% on 05/30/25
  • IV Low 19.66% on 08/15/25
  • Expected Move (DTE 6) 7.29 (2.17%)
  • Put/Call Vol Ratio 0.48
  • Today's Volume 4,830
  • Volume Avg (30-Day) 9,657
  • Put/Call OI Ratio 0.81
  • Today's Open Interest 120,923
  • Open Int (30-Day) 106,845
  • Expected Range 329.50 to 344.08

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 36 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $5.60
  • Number of Estimates 12
  • High Estimate $6.23
  • Low Estimate $5.30
  • Prior Year $6.02
  • Growth Rate Est. (year over year) -6.98%

Price Performance

See More
Period Period Low Period High Performance
1-Month
320.52 +5.08%
on 05/05/26
349.54 -3.65%
on 04/30/26
-1.23 (-0.36%)
since 04/29/26
3-Month
320.52 +5.08%
on 05/05/26
391.29 -13.93%
on 03/02/26
-51.37 (-13.23%)
since 02/27/26
52-Week
267.83 +25.75%
on 06/23/25
391.29 -13.93%
on 03/02/26
+58.39 (+20.97%)
since 05/28/25

Most Recent Stories

More News
AMGEN TO PRESENT AT JEFFERIES GLOBAL HEALTHCARE CONFERENCE

THOUSAND OAKS, Calif. , May 29, 2026 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at Jefferies Global Healthcare Conference at 9:55 a.m. ET on Thursday, June 4, 2026. Peter Griffith, executive...

AMGN : 336.79 (+0.09%)
Is Merck & Co. Stock Outperforming the S&P 500?

Merck & Co. has surged past the S&P 500 Index over the past year, and analysts remain somewhat optimistic about the stock’s growth potential.

$SPX : 7,580.06 (+0.22%)
MRK : 118.72 (-0.98%)
TERN : 52.95 (+0.04%)
AMGN : 336.79 (+0.09%)
Ember LifeSciences announces new strategic investments boosting Series A to $27M

LOS ANGELES , May 27, 2026 /PRNewswire/ -- Ember LifeSciences, Inc ., ("Ember") a leading provider of revolutionary cold chain technology, today announced strategic investments from Amgen Ventures,...

AMGN : 336.79 (+0.09%)
Why Wall Street Thinks This Dividend Stock Could Jump 30%

Amgen stock could offer attractive long-term upside for investors willing to ride through near-term volatility.

NVO : 45.58 (+0.15%)
LLY : 110.50 (-90.19%)
AMGN : 336.79 (+0.09%)
This AI Biotech Stock Landed a $10.4 Million Nvidia Investment

Nvidia’s backing highlights growing confidence in AI-powered biotech stocks.

NVDA : 211.14 (-1.45%)
GENB : 13.12 (+0.23%)
NVS : 150.17 (-0.81%)
AMGN : 336.79 (+0.09%)
AMGEN ANNOUNCES RETIREMENT OF CHIEF FINANCIAL OFFICER PETER GRIFFITH

Thomas Dittrich Returning to Amgen as CFO

AMGN : 336.79 (+0.09%)
3 Large-Cap Stocks Worth Investigating

3 Large-Cap Stocks Worth Investigating

SNOW : 255.55 (+6.84%)
EME : 826.82 (-2.55%)
AMGN : 336.79 (+0.09%)
2 Cash-Producing Stocks on Our Watchlist and 1 We Turn Down

2 Cash-Producing Stocks on Our Watchlist and 1 We Turn Down

NFLX : 86.02 (-0.39%)
SCI : 75.19 (-1.44%)
AMGN : 336.79 (+0.09%)
FDA Commissioner Marty Makary Resigns Amid Leadership Turmoil and Biotech Industry Backlash

US Food and Drug Administration Commissioner Marty Makary is resigning after 13 months in the role, according to President Donald Trump, marking another leadership shakeup across federal health agencies....

KO : 79.01 (-1.74%)
MRNA : 47.19 (-0.80%)
AMGN : 336.79 (+0.09%)
AMGEN TO PRESENT AT THE BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE

THOUSAND OAKS, Calif. , May 7, 2026 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the Bank of America Merrill Lynch Global Healthcare Conference at 10:00 a.m. PT on Wednesday, May 13, 2026. Peter...

AMGN : 336.79 (+0.09%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Amgen Inc. is the leading biotech companies world wide, with a strong presence in the oncology/hematology, cardiovascular disease, neuroscience, inflammation, bone health & nephrology and neuroscience markets. It developed two most successful drugs, Epogen & Neupogen. Amgen successfully launched two...

See More

Key Turning Points

3rd Resistance Point 342.96
2nd Resistance Point 340.24
1st Resistance Point 338.51
Last Price 336.79
1st Support Level 334.06
2nd Support Level 331.34
3rd Support Level 329.61

See More

52-Week High 391.29
Fibonacci 61.8% 344.13
Last Price 336.79
Fibonacci 50% 329.56
Fibonacci 38.2% 314.99
52-Week Low 267.83

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.